Researchers at Umeå University have identified two human cell proteins, NUP98 and NUP153, that play a crucial role in how viruses such as tick-borne encephalitis virus (TBEV), West Nile virus, and dengue virus replicate in the body. The findings challenge existing views of how these viruses exploit human cells and point to new, promising targets for future antiviral drugs.

Artificial intelligence (AI) is rapidly transforming heart failure (HF) management, offering advances from early risk prediction to treatment and continuous monitoring. A recent review led by Professor Yi-Da Tang highlights how AI integrates electronic health records, multimodal imaging, and wearable technologies to enable personalized HF care. While challenges in generalizability, interpretability, and reliability remain, ongoing innovation and validation efforts are expected to accelerate clinical translation and improve outcomes for HF patients.

Sox9, a master regulator of cartilage formation, switches its target genes dynamically during embryonic limb development instead of following a fixed program, as reported by researchers from Science Tokyo. They analyzed mouse embryonic forelimb cells across different developmental stages using single-cell-level gene expression analysis and a state-of-the-art technique to detect Sox9’s DNA binding sites. The findings lay the foundation for future research on skeletal diseases and regenerative medicine.

Integrating mechanobiological principles into disease pathogenesis, therapeutic development, and tissue engineering is reshaping our understanding of biological systems and accelerating the advancement of mechanotherapy and mechanohealth. This field reveals how mechanical cues regulate cellular behavior, such as force transmission along integrin-nucleus pathways and collective cell migration, and tissue functions. In doing so, mechanobiology connects fundamental research with clinical applications, from limiting cancer metastasis and fibrosis to promoting bone regeneration and maintaining vascular homeostasis. Building on discussion from the Inaugural International Conference on Mechanobiology (ICM) 2025, integrating mechanobiological research with clinical strategies offers new opportunities to address unmet needs, including personalized anti-fibrotic interventions or precision bone regenerative therapies. At the same time, it supports the broader concept of mechanohealth -- a paradigm focused on preserving the physiological mechanical balance within tissues.